References
- Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the incidence of inflammatory bowel disease. Lancet 1997; 349: 472–3
- Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766–7
- Wurzelman JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994; 39: 555–60
- Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11: 543–6
- Lotz M, Gutle D, Walther S, Menard S, Bognad C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006; 203: 973–84
- Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516–20
- Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard J, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
- van Heel DA, McGovern DPB, Jewell DP. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 2001; 357: 1902–3
- Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Orner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterolgy 2002; 122: 44–54
- Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
- Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 1301–8
- The Swedish National Board of Health and Welfare. The Swedish Hospital Discharge Register 1987–1996 Quality and Contents. 1998. Stockholm, Sweden Ref Type: Report.
- Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511–21
- van den Bogaerde J, Kamm MA, Knight SC. Immune sensitization to food, yeast and bacteria in Crohn's disease. Aliment Pharmacol Ther 2001; 15: 1647–53
- Tiwana H, Wilson C, Walmsley RS, Wakefield AJ, Smith MSN, Cox NL, et al. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 1997; 17: 11–6
- Kirsner JB. The historical basis of the idiopathic inflammatory bowel diseases. Inflamm Bowel Dis 1995; 1: 2–26
- Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev 1986; 8: 60–91
- Ehlin AGC, Montgomery SM, Ekbom A, Pounder RE, Wakefield AJ. Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut 2003; 52: 1117–21
- Armitage E, Drummond HE, Wilson DC, Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001; 13: 1439–47
- Hildebrand H, Finkel Y, Grahnquist L, Lindholm J, Ekbom A, Askling J. Changing pattern of paediatric inflammatory bowel disease in Northern Stockholm –2001. Gut ;52 1990; 2003: 1432–4
- Mayberry JF, Dew MJ, Morris JS, Powell DB. An audit of Crohn's disease in a defined population. J R Coll Physicians Lond 1983; 17: 196–8
- Montgomery SM, Morris DL, Thompson NP, Subhani J, Pounder RE, Wakefield AJ. Prevalence of inflammatory bowel disease in British 26-year-olds: national longitudinal birth cohort. Br Med J 1998; 316: 1058–9
- Pido-Lopez J, Imami N, Aspinall R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin Exp Immunol 2000; 125: 409–13
- Percival RS, Marsh PD, Challacombe SJ. Serum antibodies to commensal oral and gut bacteria vary with age. Fems Immunol Med Microbiol 1996; 15: 35–42